#USA #Addison #FX Shoulder #shoulder arthroplasty #Humelock Reversed

FX Shoulder Solutions Achieves EU MDR Certification for Humelock Reversed® Shoulder System

In a significant advancement for shoulder arthroplasty, FX Shoulder Solutions, Inc. proudly announced that its Humelock Reversed® Shoulder System has attained certification under the European Union Medical Device Regulation (EU MDR 2017/745). This milestone represents a crucial initial step in the company’s strategy to harmonize its product offerings across international markets, thereby ensuring a seamless transition of product availability and a consistent experience for healthcare providers worldwide.

As a leader in shoulder surgical innovation, FX Shoulder Solutions aims to combine established clinical performance with next-generation technologies. The Humelock Reversed® has been at the forefront of these efforts, characterized by its strong track record and commitment to effective patient outcomes. This announcement triggers the beginning of a new phase in the company’s international expansion, reflecting their dedication to enhancing shoulder reconstruction solutions globally.

A Commitment to Clinical Excellence

The Humelock Reversed® system is based on an established lineage that has been supported by robust post-market clinical follow-up (PMCF) studies. In a cohort of 138 patients monitoring the device for over three years, it demonstrated exceptional performance with a low revision rate of just 0.72% for instability issues. Only 1.45% of the cohort required device-related revisions, underscoring the reliability of the Humelock platform.

These promising clinical outcomes reassure surgeons and patients alike of the Humelock Reversed®’s stability and long-term effectiveness. The system’s performance metrics clearly reflect FX’s dedication to high standards in medical device manufacturing and patient care, directly resonating with their mission of improving surgical outcomes significantly.

Strategic Expansion Through Certification

Achieving EU MDR certification signifies much more than compliance for FX Shoulder Solutions; it is a strategic move to consolidate their global presence. CEO Baptiste Martin emphasized the importance of this achievement, stating that it represents a pivotal moment in the journey towards a unified FX portfolio across various international markets. The company continues to challenge the norms of shoulder arthroplasty through meaningful innovations, intending to streamline surgical procedures while expanding their product range.

Alongside this certification, FX plans to roll out enhanced product offerings, including more diverse implant options and improved surgical instruments. The company is committed to providing comprehensive solutions that not only meet the needs of today’s orthopedic surgeons but also maintain high clinical evidence backing.

Future Forward: Innovative Solutions

FX Shoulder Solutions possesses a distinct range of products including stemless reconstruction, primary shoulder arthroplasty, and solutions for complex fractures and revisions. This diverse portfolio highlights their commitment to evolving technologies that directly respond to the changing landscape of shoulder reconstruction.

With the EU MDR certification now in hand, FX is set to enhance its offerings further, ensuring that the next generation of surgical solutions remains at the cutting edge of innovation. This certification acts as a foundation for broadening their influential role in the international shoulder arthroplasty market, solidifying their reputation as a primary innovator in medical technology.

FX Shoulder Solutions is dedicated to not just expanding their range but ensuring that every product provides real-world surgical flexibility and reliability. Future developments will continually be informed by clinical outcomes and surgeon feedback, demonstrating FX’s commitment to excellence in healthcare.

About FX Shoulder Solutions

Headquartered in Addison, Texas, FX Shoulder Solutions, Inc. specializes in the development of advanced shoulder arthroplasty devices. With a focus on clinical evidence and surgical efficiency, FX is recognized for its innovative contributions to the shoulder surgery field. For more information about their products and initiatives, visit www.fxshouldersolutions.com.